Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANX-K: Topical Tranexamic Acid in Primary Cemented Total Knee Replacement
2007-007813-35Phase 4Completed
- Sponsor
- North Tees and Hartlepool NHS Foundation Trust
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in knee osteoarthritis (OA) and osteoarthritis (OA) (2 arms), sponsored by North Tees and Hartlepool NHS Foundation Trust. Primary endpoint: Drain blood loss (first 48 hours). Started Mar 2008; status: completed.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2007-007813-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007813-35.